VP, Immunology Global Medical Affairs- Gastroenterology & Autoantibody

Johnson & Johnson is currently seeking a VP, Immunology Global Medical Affairs - Gastroenterology & Autoantibody (GI/AAb) to join our Global Medical Affairs organization located in Horsham, PA.

At Johnson & Johnson,we believe health is everything.

Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.

Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at https://www.jnj.com/.

For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day.

Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world.

Our diverse workforce and culture of belonging accelerate innovation to solve the world's most pressing healthcare challenges.
We know that the success of our business - and our ability to deliver meaningful solutions - depends on how well we understand and meet the diverse needs of the communities we serve.

Which is why we foster a culture of inclusion and belonging where all perspectives, abilities and experiences are valued and our people can reach their potential.
At Johnson & Johnson, we all belong.

The VP, IMM GMAF GI & AAb will lead the GMAF GI & AAb medical teams and will work closely with Regional/Country MAF teams, Market Access, Commercial teams, Research and Development (R&D), and Compound Development team (CDT) to develop and execute medical activities.

This role is responsible for leading and accelerating the delivery of innovative medical affairs strategies, rigorous medical launch plans, worldwide integrated evidence generation plans and comprehensive scientific communications & external engagement plans.

This role will ensure dedicated focus on speed to impact for the GI & AAb portfolio which includes TREMFYA, nipocalimab, JNJ-2113, and JNJ-4804.

The VP, GI/AAb will have accountability for developing new skills and capabilities required to launch new modalities and build expertise for launching therapies where treatments are first or only in market.

Strategy
• Design overarching strategic and tactical plans necessary to grow Johnson & Johnson's world class GI/AAb portfolios resulting in transformational patient outcomes
• Provide strategic direction in close collaboration with internal stakeholders: (R&D, CDT, medical affairs teams and Commercial partners, Market Access and others) across the medicine life-cycle.

Medicines include TREMFYA, nipocalimab, JNJ-2113, and JNJ-4804.
• Development of a strategic portfolio approach in GI & AAb.
• Shape clinical development of lifecycle and new products through insights and needs of worldwide market captured...